Many people treated with statins and other cholesterol lowering drugs have a modifiable residual risk of cardiovascular disease because their low density lipoprotein cholesterol (LDL-C) is still too high.

Professor Kausik Ray says there is an unmet need for improved treatments in patients who cannot tolerate statins or those who do not achieve LDL-C target on currently available treatments.

To find out more visit www.pcsk9forum.org.

свернуть